Re: Question on upcoming version 1.5

Hello Todd,

Gleason, Todd wrote:
> I would be interested in seeing what FDA requirement specifies merge
> tracking support in a version control system, because this is the first
> I've heard of it.
>
> Perhaps the "FDA requirement" is not specifically for merge tracking,
> but simply to have proper documentation of bugs fixed in a particular
> branch?
Indeed, yes. The FDA simply requires to have full traceability of
changes. It typically doesn't mandate any specific technological solution.

> (And merge tracking is very useful for this, but not the only
> means to this end.)
Precisely.

Ph. A.

>
> -----Original Message-----
> From: Philippe Andersson [mailto:pan_at_iba-group.com]
> Sent: Friday, June 06, 2008 8:37 AM
> To: users_at_subversion.tigris.org
> Subject: Question on upcoming version 1.5
>
> Hello list,
>
> I'm investigating the feasability of implementing our current SCM plan
> in Subversion, with the goal of replacing our current tool (ClearCase)
> over time.
>
> One rather crucial aspect for us is merge tracking support (FDA
> requirement -- we manufacture medical devices). Hence my interest in
> version 1.5.
>
> I've read this document:
>
> <http://subversion.tigris.org/merge-tracking/requirements.html>
>
> that lists the use cases to be covered by merge tracking, and I'm quite
> happy with what it contains.
>
> Now my question: can someone tell me / point me to a document that
> details how much of those use cases are indeed implemented in the
> upcoming version 1.5 (or will be, when it is officially released) ?
>
> Thanks in advance,
>
> Ph. A.
>

-- 
*Philippe Andersson*
Unix System Administrator
IBA Particle Therapy |
Tel: +32-10-475.983
Fax: +32-10-487.707
eMail: pan_at_iba-group.com
<http://www.iba-worldwide.com>
The contents of this e-mail message and any attachments are intended solely for 
the recipient (s) named above. This communication is intended to be and to 
remain confidential and may be protected by intellectual property rights. Any 
use of the information contained herein (including but not limited to, total or 
partial reproduction, communication or distribution of any form) by persons 
other than the designated recipient(s) is prohibited. Please notify the sender 
immediately by e-mail if you have received this e-mail by mistake and delete 
this e-mail from your system. E-mail transmission cannot be guaranteed to be 
secure or error-free. Ion Beam Applications does not accept liability for any 
such errors. Thank you for your cooperation.